4/17/2012

Retinal pigment epithelial cells derived from human embryonic stem cells were administered to a second patient in a Phase I/II trial involving dry age-related macular degeneration. The Advanced Cell Technology treatment is being tested in three clinical trials in the U.S. and Europe.

Related Summaries